Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
25.2M
-
Shares change
-
-510K
-
Total reported value, excl. options
-
$71.3M
-
Value change
-
-$3.22M
-
Put/Call ratio
-
0
-
Number of buys
-
37
-
Number of sells
-
-21
-
Price
-
$2.83
Significant Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 per share (SKYE) as of Q4 2024
85 filings reported holding SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Skye Bioscience, Inc. - Common Stock, par value $0.001 per share (SKYE) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.2M shares
of 31M outstanding shares and own 81.32% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (9.91M shares), Versant Venture Management, LLC (2.01M shares), SPHERA FUNDS MANAGEMENT LTD. (1.56M shares), BAKER BROS. ADVISORS LP (1.45M shares), Schonfeld Strategic Advisors LLC (1.42M shares), BlackRock, Inc. (1.22M shares), Altium Capital Management LLC (1.14M shares), VANGUARD GROUP INC (861K shares), BRAIDWELL LP (826K shares), and Ensign Peak Advisors, Inc (767K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.